CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The ...
Phase 2
Indianapolis, Indiana, United States and 23 other locations
This open-label, non-randomized Phase II trial is designed to assess the safety and tolerability of GT103 in combination with pembrolizumab ...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Indianapolis, Indiana, United States and 275 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Indianapolis, Indiana, United States and 262 other locations
This study is an open label, multicenter, randomized phase II trial of consolidation immunotherapy with either nivolumab alone or the combination of...
Phase 2
Indianapolis, Indiana, United States and 11 other locations
This is an open label, multi-institutional, single arm study with a dose escalation phase Ib cohort, followed by a phase II cohort of pembrolizumab a...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 4 other locations
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...
Phase 3
Indianapolis, Indiana, United States and 233 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Indianapolis, Indiana, United States and 204 other locations
observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) wit...
Phase 2
Indianapolis, Indiana, United States and 12 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell...
Phase 1
Indianapolis, Indiana, United States and 24 other locations
Clinical trials
Research sites
Resources
Legal